More than 50 years of landmark results
Since 1967, Lowey Dannenberg has represented investors and major corporations in complex litigation, recovering billions of dollars on their behalf.Solutions for Complex Cases
Professional Recommendations
Recent Cases
Shelled Eggs
Antitrust, Commodities
On June 8, Lowey Dannenberg Chairman Vincent Briganti was appointed as Co-Lead Counsel for the Direct Purchaser Plaintiffs in In Re: Shell Eggs Antitrust Litigation, No. 3:26-md-03175-JDP (W.D. Wisc.) Plaintiffs […]
Amitza
Healthcare
Lowey Dannenberg, on behalf of named plaintiff Premera Blue Cross, is leading a class on behalf of Third-Party Payers of Amitiza (Lubiprostone) against Takeda Pharmaceutical Company Ltd. and related entities. […]
Amgen
Health Care, Healthcare
On September 30, 2025, the U.S. District Court for the Eastern District of Virginia largely denied Amgen’s motion to dismiss in CareFirst of Maryland Inc. et al. v. Amgen Inc. […]
News
Lowey Dannenberg, P.C. Ranked #1 Law Firm Based on Antitrust Settlements
Lowey Dannenberg P.C. is proud to announce that the firm has been included in this year’s ISS Securities Class Action Services (“ISS SCAS”) Top Plaintiff Law Firms of 2023 report, as the Firm was ranked #1 Law Firm based on Antitrust Settlements. The Firm topped the...
Blog
23andMe’s Business Strategy Highlights the Need for More Data Privacy Laws
23andMe rose to success by selling at home DNA tests ultimately purchased by more than 11 million individuals. By some estimates 1 in 5 Americans have handed over their DNA to 23andMe or companies like it.[1] But for many of these individuals, while they may believe that 23andMe is only using...